Osterweis Capital Management Inc Axonics, Inc. Transaction History

Osterweis Capital Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$49.38 - $63.75 $2.1 Million - $2.71 Million	42,439 Added 69.37%	103,614 $6.45 Million
Q3 2023 Nov 14, 2023	BUY	$48.64 - $62.51 $2.98 Million - $3.82 Million	61,175 New	61,175 $3.43 Million
Q1 2021 May 14, 2021	SELL	$49.14 - $59.89 $7.84 Million - $9.55 Million	-159,505 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$42.19 - $51.5 $1.2 Million - $1.47 Million	28,500 Added 21.75%	159,505 $7.96 Million
Q3 2020 Nov 13, 2020	BUY	$35.33 - $51.04 $118,355 - $170,984	3,350 Added 2.62%	131,005 $6.69 Million
Q2 2020 Aug 14, 2020	SELL	$22.91 - $39.83 $983,526 - $1.71 Million	-42,930 Reduced 25.17%	127,655 $4.48 Million
Q1 2020 May 15, 2020	BUY	$16.44 - $37.73 $2.8 Million - $6.44 Million	170,585 New	170,585 $4.34 Million

234

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Osterweis Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Osterweis Capital Management Inc with notifications on news.